ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 365

Classifying Pseudogout Using Machine Learning Approaches with Electronic Health Record Data

Sara K. Tedeschi1, Tianrun Cai 2, Zeling He 3, Yuri Ahuja 4, Chuan Hong 5, Katherine Yates 4, Kumar Dahal 2, Chang Xu 3, Houchen Lyu 2, Kazuki Yoshida 6, Daniel Solomon 7, Tianxi Cai 5 and Katherine Liao 2, 1Brigham and Women's Hospital, Div. of Rheumatology, Immunology and Allergy, Boston, MA, 2Brigham and Women's Hospital, Boston, 3Brigham and Women's Hospital, Boston, MA, 4Harvard Medical School, Boston, 5Harvard T.H. Chan School of Public Health, Boston, 6Brigham and Women's Hospital, Div. of Rheumatology, Immunology and Allergy, Boston, 7Brigham and Women´s Hospital, Div. of Rheumatology, Immunology and Allergy, Boston, MA

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: algorithm, calcium pyrophosphate dihydrate (CPPD) and Electronic Health Record, machine learning, pseudogout

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 10, 2019

Title: Metabolic & Crystal Arthropathies Poster I: Clinical

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Identifying pseudogout in large administrative datasets has been difficult due to lack of specific billing codes for this acute subtype of calcium pyrophosphate (CPP) crystal deposition disease. While several machine learning approaches exist to phenotype patients using electronic health record (EHR) data, they are largely validated in chronic conditions with relatively accurate billing codes. Pseudogout poses unique challenges due to its lack of specific billing codes and episodic nature. We evaluated a novel machine learning approach for classifying definite/probable pseudogout using EHR data.

Methods: We created an EHR dataset of 30,089 patients with ≥1 relevant billing code (Table 1 footnote) or ≥2 natural language processing (NLP) mentions of pseudogout or chondrocalcinosis in narrative notes, 1990-2017. We randomly selected 900 patients for gold standard chart review to label as: (1) definite pseudogout, synovitis+synovial fluid CPP crystals; (2) probable pseudogout, synovitis+chondrocalcinosis; (3) not pseudogout. Presence of synovial fluid CPP crystals was determined by manual review of lab results recorded as free text in the EHR. To develop an algorithm for identifying definite/probable pseudogout vs. not, we applied a semi-supervised topic modeling approach; presence of CPP crystals was not included since it required manual review. The approach included the score from an unsupervised topic modeling method including all relevant features; NLP mentions of pseudogout; and whether synovial fluid crystal analysis was performed regardless of result. We created a combined algorithm including information from the semi-supervised topic modeling approach and the manually reviewed CPP crystal results. We compared algorithm accuracy and cohorts identified by: (1) billing codes, (2) presence of CPP crystals, (3) the combined algorithm.

Results: Among the 900 subjects, 123 (13.7%) had pseudogout by chart review (68 definite, 55 probable). Billing codes alone had a sensitivity 65% and PPV 22% for definite/probable pseudogout (Table 1). Presence of CPP crystals had a sensitivity 29% and PPV 92%. Without using the CPP crystal result, the semi-supervised topic modeling algorithm had a sensitivity 29% and PPV 79%. The combined algorithm yielded a sensitivity 42% and PPV 81%. The cohort identified by the combined algorithm (n=2490) was 50% larger than that identified by presence of CPP crystals (n=1630); the latter only captured patients with definite pseudogout and did not identify patients with probable pseudogout. Table 2 demonstrates important differences between cohorts identified via billing codes vs. the combined algorithm, and similarities between cohorts identified by the presence of CPP crystals vs. the combined algorithm.

Conclusion: For pseudogout, a condition without a specific billing code, combining NLP and machine learning methods with synovial fluid CPP crystal lab results yielded an algorithm that significantly boosted PPV compared to billing codes alone, with modest sensitivity. This balance allows classification of a large pseudogout cohort for future research.


Table 1 2019.05.30


Table 2 2019.05.30


Disclosure: S. Tedeschi, None; T. Cai, None; Z. He, None; Y. Ahuja, None; C. Hong, None; K. Yates, None; K. Dahal, None; C. Xu, None; H. Lyu, None; K. Yoshida, None; D. Solomon, AbbVie, 2, Abbvie, 2, Amgen, 2, AstraZeneca, 2, Corrona, 2, Genentech, 2, Janssen, 2, Lilly, 2, Pfizer, 2; T. Cai, None; K. Liao, None.

To cite this abstract in AMA style:

Tedeschi S, Cai T, He Z, Ahuja Y, Hong C, Yates K, Dahal K, Xu C, Lyu H, Yoshida K, Solomon D, Cai T, Liao K. Classifying Pseudogout Using Machine Learning Approaches with Electronic Health Record Data [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/classifying-pseudogout-using-machine-learning-approaches-with-electronic-health-record-data/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/classifying-pseudogout-using-machine-learning-approaches-with-electronic-health-record-data/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology